Related Experiment Video

Updated: Aug 23, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Principles of Wilms' tumor biology

M J Coppes1, K Pritchard-Jones

  • 1Southern Alberta Children's Cancer Program, University of Calgary, Alberta, Canada. max.coppes@crha-health.ab.ca

The Urologic Clinics of North America
|September 14, 2000
PubMed

Insights

Recent genetic discoveries are improving Wilms tumor treatment. Understanding kidney development genetics allows tailored therapies, intensifying care for high-risk patients and reducing side effects for those with favorable prognoses.

Area of Science:

  • Pediatric oncology
  • Molecular genetics
  • Developmental biology

Background:

  • Wilms tumor (nephroblastoma) is the most common pediatric kidney cancer.
  • Recent advances have elucidated key genetic factors in Wilms tumorigenesis and normal kidney development.
  • Understanding these genetic underpinnings is crucial for refining clinical strategies.

Purpose of the Study:

  • To summarize recent breakthroughs in the genetic understanding of Wilms tumor and kidney development.
  • To discuss the clinical implications of these genetic findings for patient management.
  • To outline current treatment strategies based on prognostic features.

Main Methods:

  • Review of recent scientific literature on Wilms tumor genetics and pediatric kidney development.
  • Analysis of current treatment protocols and outcomes from the National Wilms Tumor Study Group (NWTSG).

Main Results:

  • Significant progress has been made in identifying genetic factors contributing to Wilms tumor development.
  • Over 80% of patients with Wilms tumor achieve cure with current multimodal therapies.
  • Treatment intensification for poor-prognosis cases and de-escalation for favorable-prognosis cases are being implemented.

Conclusions:

  • Genetic insights are transforming the approach to Wilms tumor management.
  • Tailored therapeutic strategies based on genetic and prognostic factors are improving outcomes and reducing treatment toxicity.
  • Continued research into Wilms tumorigenesis genetics holds promise for further advancements in pediatric cancer care.

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Zebrafish Model of Neuroblastoma Metastasis05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...